Evaluation of Humira Retention Rate in Psoriasis Patients in Daily Practice and Assessment of Work Productivity and Quality of Life
Phase of Trial: Phase IV
Latest Information Update: 14 Jul 2016
At a glance
- Drugs Adalimumab (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Abbott Laboratories; AbbVie
- 08 Apr 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 19 Feb 2015 Planned End Date changed from 1 Jan 2015 to 1 Apr 2015 as reported by ClinicalTrials.gov.
- 19 Feb 2015 Planned primary completion date changed from 1 Jan 2015 to 1 Apr 2015 as reported by ClinicalTrials.gov.